SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/65C6AD4BED5F1F5E4DDDEB4E255A1FB2C3B25D072F8C3B2BEE9490BF9AC893C174D43623ED09C3BAED9E898E23D19E1D>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/65C6AD4BED5F1F5E4DDDEB4E255A1FB2C3B25D072F8C3B2BEE9490BF9AC893C174D43623ED09C3BAED9E898E23D19E1D
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/65C6AD4BED5F1F5E4DDDEB4E255A1FB2C3B25D072F8C3B2BEE9490BF9AC893C174D43623ED09C3BAED9E898E23D19E1D
http://www.w3.org/2000/01/rdf-schema#comment
"Genetic polymorphisms of tumour necrosis factor receptor superfamily 1a ... are associated with clinical efficacy and/or acute severe infusion reactions to infliximab in Crohn's disease."
xsd:string
http://purl.uniprot.org/uniprot/#_3E5410E8BA78271E56E7DBC5E9D3834F15A0FC881DFBA08288AC6346A3CE5069BD172DC75A2797942A72525CD3550213
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/65C6AD4BED5F1F5E4DDDEB4E255A1FB2C3B25D072F8C3B2BEE9490BF9AC893C174D43623ED09C3BAED9E898E23D19E1D
http://purl.uniprot.org/uniprot/P19438
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/65C6AD4BED5F1F5E4DDDEB4E255A1FB2C3B25D072F8C3B2BEE9490BF9AC893C174D43623ED09C3BAED9E898E23D19E1D
http://purl.uniprot.org/uniprot/#_P19438-mappedCitation-22860894
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/65C6AD4BED5F1F5E4DDDEB4E255A1FB2C3B25D072F8C3B2BEE9490BF9AC893C174D43623ED09C3BAED9E898E23D19E1D